Published in Pol Merkur Lekarski on May 01, 2014
Serum procalcitonin level and other biological markers to distinguish between bacterial and aseptic meningitis in children: a European multicenter case cohort study. Arch Pediatr Adolesc Med (2008) 1.70
Management of familial heterozygous hypercholesterolemia: Position Paper of the Polish Lipid Expert Forum. J Clin Lipidol (2013) 1.58
Immunogenecity of hepatitis A vaccine in pediatric patients with inflammatory bowel disease. Inflamm Bowel Dis (2010) 1.49
Does sodium intake affect the relationship between blood pressure and vascular damage? Pol Arch Med Wewn (2015) 1.40
Increased prevalence of cardiovascular risk factors in patients with acute coronary syndrome and indications for treatment with oral anticoagulation. Kardiol Pol (2011) 1.40
Towards Participatory Geographic Information Systems for community-based environmental decision making. J Environ Manage (2008) 1.35
Arterial stiffness, pulse pressure, and cardiovascular disease-is it possible to break the vicious circle? Atherosclerosis (2011) 1.15
Mucosal bacterial microflora and mucus layer thickness in adolescents with inflammatory bowel disease. World J Gastroenterol (2009) 1.12
Arterial stiffness, central hemodynamics, and cardiovascular risk in hypertension. Vasc Health Risk Manag (2011) 1.02
Central blood pressure and hypertension: role in cardiovascular risk assessment. Clin Sci (Lond) (2009) 0.97
Modern approach for determination of lactulose, mannitol and sucrose in human urine using HPLC-MS/MS for the studies of intestinal and upper digestive tract permeability. J Chromatogr B Analyt Technol Biomed Life Sci (2012) 0.94
Distribution of HCV genotypes in Poland. Przegl Epidemiol (2013) 0.91
Procalcitonin to reduce the number of unnecessary cystographies in children with a urinary tract infection: a European validation study. J Pediatr (2007) 0.91
Depression, anxiety, and risk factor control in patients after hospitalization for coronary heart disease: the EUROASPIRE III Study. Eur J Prev Cardiol (2012) 0.90
The Foker technique (FT) and Kimura advancement (KA) for the treatment of children with long-gap esophageal atresia (LGEA): lessons learned at two European centers. Eur J Pediatr Surg (2013) 0.90
Benefits of the RAS blockade: clinical evidence before the ONTARGET study. J Hypertens Suppl (2009) 0.90
Endoscopic ligation of esophageal varices for prophylaxis of first bleeding in children and adolescents with portal hypertension: preliminary results of a prospective study. J Pediatr Surg (2003) 0.89
Usefulness of faecal calprotectin measurement in children with various types of inflammatory bowel disease. Mediators Inflamm (2012) 0.88
Potential energy surface for interactions between two hydrogen molecules. J Chem Phys (2008) 0.87
The influence of experimental Bacteroides fragilis infection on substance P and somatostatin-immunoreactive neural elements in the porcine ascending colon - a preliminary report. Folia Morphol (Warsz) (2003) 0.87
What do Polish interventional cardiologists know about indications and qualification for recanalisation of chronic total coronary artery occlusions? Kardiol Pol (2015) 0.87
Cystic fibrosis is a risk factor for celiac disease. Acta Biochim Pol (2010) 0.86
Distinguishing between bacterial and aseptic meningitis in children: European comparison of two clinical decision rules. Arch Dis Child (2010) 0.86
A common origin of the 4143insA ADAMTS13 mutation. Thromb Haemost (2006) 0.86
[Diagnostic role of upper gastrointestinal endoscopy in pediatric inflammatory bowel diseases]. Pol Merkur Lekarski (2008) 0.86
Recanalisation of coronary chronic total occlusion by retrograde approach: the first experience in Poland. Kardiol Pol (2014) 0.85
[Blue rubber bleb naevus syndrome]. Pol Merkur Lekarski (2012) 0.85
Treatment of Helicobacter pylori infection in the aspect of increasing antibiotic resistance. Adv Clin Exp Med (2013) 0.85
Epidemiology of inflammatory bowel disease among children in Poland. A prospective, population-based, 2-year study, 2002-2004. Digestion (2009) 0.85
Lamivudine therapy for children with chronic hepatitis B. World J Gastroenterol (2006) 0.84
Hepatic vein thrombosis as a complication of ulcerative colitis in a 12-year-old patient. Dig Dis Sci (2007) 0.84
Pulmonary artery pulse wave velocity in idiopathic pulmonary arterial hypertension. Can J Cardiol (2012) 0.82
Helicobacter pylori increases expression of proapoptotic markers Fas and FasL on CD4 lymphocytes in children. Acta Biochim Pol (2009) 0.81
Second virial coefficients of H2 and its isotopologues from a six-dimensional potential. J Chem Phys (2012) 0.81
[Prophylaxis of vitamin D deficiency--Polish recommendations 2009]. Pol Merkur Lekarski (2010) 0.81
Essential fatty acid depletion in children with inflammatory bowel disease. Scand J Gastroenterol (2005) 0.80
[Parenteral symptoms and intestinal complications in children with inflammatory bowel diseases in relation to card15 mutation]. Med Wieku Rozwoj (2009) 0.80
Immunohistochemical distribution of cocaine- and amphetamine-regulated transcript peptide - like immunoreactive (CART-LI) nerve fibers and various degree of co-localization with other neuronal factors in the circular muscle layer of human descending colon. Histol Histopathol (2012) 0.80
[Intestinal complications and extraintestinal manifestations in children with inflammatory bowel disease]. Pol Merkur Lekarski (2006) 0.80
A Randomized, Prospective Study of Pediatric Patients With Community-acquired Pneumonia Treated With Ceftaroline Versus Ceftriaxone. Pediatr Infect Dis J (2016) 0.79
Lipid-lowering drugs and homocysteine. A comparison between statins and other lipid-lowering drugs. Atherosclerosis (2004) 0.79
Neutrophil gelatinase-associated lipocalin in blood in children with inflammatory bowel disease. J Gastroenterol Hepatol (2014) 0.79
Helicobacter pylori antigens in stool specimens of gastritis children before and after treatment. J Pediatr Gastroenterol Nutr (2003) 0.79
[Prophylaxis of vitamin D deficiency--Polish recommendation 2009]. Ginekol Pol (2010) 0.79
Antihypertensive therapy and de-stiffening of the arteries. Expert Opin Pharmacother (2010) 0.79
[Predisposing factors and results of pharmalogical treatment using ursodeoxycholic acid of gallbladder stones in children]. Pol Merkur Lekarski (2006) 0.79
[Hemophagocytic syndrome in children with different underlying conditions]. Przegl Lek (2010) 0.78
Invasive properties, adhesion patterns and phylogroup profiles among Escherichia coli strains isolated from children with inflammatory bowel disease. Adv Clin Exp Med (2013) 0.78
Serologic investigations in children with inflammatory bowel disease and food allergy. Mediators Inflamm (2009) 0.78
Clinical implications of non-invasive measurement of central aortic blood pressure. Curr Vasc Pharmacol (2010) 0.78
Intraaortic pulse pressure amplification in subjects at high coronary risk. Hypertension (2010) 0.78
[Urokinase plasminogen activator (u-PA) and urokinase type plasminogen activator receptor (u-PAR) in children with ulcerative colitis]. Med Wieku Rozwoj (2007) 0.78
Immunogenicity of 13-Valent Pneumococcal Conjugate Vaccine in Pediatric Patients with Inflammatory Bowel Disease. Inflamm Bowel Dis (2015) 0.77
[Assessment of fecal calprotectin concentration as inflammatory marker in inflammatory bowel diseases in children--preliminary report]. Pol Merkur Lekarski (2010) 0.77
[Ascites and extreme lipid abnormalities as initial symptoms of cystic fibrosis in a 5-years-old girl--case report]. Pol Merkur Lekarski (2009) 0.77
Monotherapy with infliximab versus combination therapy in the maintenance of clinical remission in children with moderate to severe Crohn disease. J Pediatr Gastroenterol Nutr (2015) 0.77
[Selected aspects of the epidemiological analysis of celiac disease and diabetes mellitus type 1 coexistance in children and youth]. Pol Merkur Lekarski (2006) 0.77
Home enteral nutrition in children--2010 nationwide survey of the Polish Society for Clinical Nutrition of Children. Eur J Pediatr (2011) 0.77
Cost-effectiveness of a cardiovascular disease primary prevention programme in a primary health care setting. Results of the Polish part of the EUROACTION project. Kardiol Pol (2013) 0.77
[Bone mineral density in inflammatory bowel diseases in children]. Med Wieku Rozwoj (2006) 0.77
Metalloproteinase-3 and -9 as novel markers in the evaluation of ulcerative colitis activity in children. Adv Clin Exp Med (2014) 0.77
[Genetic type of Helicobacter pylori and the efficacy of eradication therapy]. Pol Merkur Lekarski (2009) 0.77
Relations between Leu(5)-enkephalin- (LENK) and VIP-immunoreactive nerve fibres during human drug-resistant colitis. A case study. Folia Morphol (Warsz) (2003) 0.77
Comparative safety and efficacy of proton pump inhibitors in paediatric gastroesophageal reflux disease. Drug Saf (2014) 0.76
[H. pylori infections in children: clinical, diagnostic and treatment implications]. Pol Merkur Lekarski (2013) 0.76
[The prevalence of dupA (duodenal ulcer-promoting gene) of Helicobacter pylori in children and adolescents--own observation]. Pol Merkur Lekarski (2013) 0.76
[Recommendations of prophylaxis of vitamin D deficiency in Poland (2009)]. Med Wieku Rozwoj (2010) 0.76
Determinants of appropriate lipid management in patients with ischaemic heart disease. Cracovian Program for Secondary Prevention of Ischaemic Heart Disease. Int J Cardiol (2003) 0.76
The mRNA level of the transforming growth factor β1 gene, but not the amount of the gene product, can be considered as a potential prognostic parameter in inflammatory bowel diseases in children. Int J Colorectal Dis (2012) 0.76
Ezetimibe: New perspectives in lipid lowering treatment. Cardiol J (2007) 0.76
Polish forum for prevention guidelines on smoking. Kardiol Pol (2008) 0.76
Somatic development disorders of children with non specific inflammatory bowel diseases. Dev Period Med (2014) 0.76
[Looking for the auditory and vestibular pathology in celiac disease]. Otolaryngol Pol (2007) 0.75
[The analysis of the hepatitis C virus infection course and efficacy of treatment dependence on HLA A antigens in children and youth]. Pol Merkur Lekarski (2008) 0.75
Pulse pressure and restenosis after percutaneous coronary angioplasty. Am J Cardiol (2002) 0.75
[Actual problems of dyslipidaemia treatment in Poland - 2nd Declaration of Sopot. Experts' Group Consensus endorsed by the Polish Cardiac Society Working Group on Cardiovascular Pharmacotherapy]. Kardiol Pol (2014) 0.75
Central blood pressure and cardiovascular risk. J Hypertens (2009) 0.75
Adaptive changes of pancreatic protease secretion to a short-term vegan diet: influence of reduced intake and modification of protein. Br J Nutr (2011) 0.75
INTERHEART. Lancet (2005) 0.75
Letter by Jankowski regarding article, "Atherosclerotic lesion size and vulnerability are determined by patterns of fluid shear stress". Circulation (2006) 0.75
[Management of familial heterozygous hypercholesterolaemia. Position paper of the Polish Lipid Expert Forum]. Kardiol Pol (2013) 0.75
Relation between ascending aortic pressures and outcomes in patients with angiographically demonstrated coronary artery disease. Am J Cardiol (2006) 0.75
The antimicrobial susceptibility of Helicobacter pylori strains isolated from children and adults with primary infection in the Lower Silesia Region, Poland. Pol J Microbiol (2014) 0.75
Letter by Safar and Jankowski regarding article, "Arterial stiffness and cardiovascular events: the Framingham Heart Study". Circulation (2010) 0.75
Relationship between reduced elasticity of extracardiac vessels and left main stem coronary artery disease. Eur Heart J (2005) 0.75
Factors related to the effectiveness of hypercholesterolemia treatment following hospitalization for coronary artery disease. Pol Arch Med Wewn (2016) 0.75
[Retrospective analysis of epidemiological and clinical aspects of acute pancreatitis in children]. Pol Merkur Lekarski (2014) 0.75
Possible under-treatment of women in Poland with Crohn's disease: a subgroup analysis from a prospective multicenter study of the use of anti-TNFs. Pol Arch Intern Med (2017) 0.75
Serotype-Specific Pneumococcal Status prior to PCV 13 Administration in Children and Adolescents with Inflammatory Bowel Disease. Pol J Microbiol (2016) 0.75
Serum Phospholipid Fatty Acid Composition in Cystic Fibrosis Patients with and without Liver Cirrhosis. Ann Nutr Metab (2017) 0.75